Safety and efficacy of perioperative lowdose esketamine for pain management in laparoscopic cholecystectomy: a systematic review and meta-analysis of randomized controlled trials
Authors: Lama Alzimami , Mohammed AlAdhab , Muath Almuhanna , Rawan Alkhammas , Afnan K. Alturki , Khadijah I. Basheikh , Yousef Abdullatif Aljohar , Norah Almulhim , Wedad Almutairi , Raha Alotaibi , Aishah Alhadi , Amal Alzahrani , Abdulaziz Alabdulaali
Abstract
Background: Laparoscopic cholecystectomy (LC) is frequently associated with early postoperative pain and opioid-related adverse effects. We evaluated the efficacy and safety of perioperative low-dose esketamine in adults undergoing LC.
Methods: Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidance, PubMed, the Cochrane Library, Embase, and Web of Science were searched from inception to February 2026 for randomized controlled trials comparing esketamine with placebo or a standard anesthetic regimen. Random-effects meta-analyses generated mean differences, standardized mean differences, or risk ratios with 95% confidence intervals (CIs).
Results: Nine trials involving 699 participants were included. Esketamine reduced pain within 2 hours (MD-0.67; 95% CI -0.90 to -0.45) and reduced pain at rest and with movement through 72 hours, although several later estimates were highly heterogeneous. Intraoperative remifentanil consumption (SMD -0.74; 95% CI -1.31 to -0.18) and propofol consumption (SMD -0.55; 95% CI -0.98 to -0.11) were lower. Awakening time, postanesthesia care unit stay, and anesthesia duration did not differ significantly. No clear increase was observed in common adverse events, including nausea, vomiting, hallucinations, or agitation.
Conclusion: Perioperative low-dose esketamine modestly reduced postoperative pain and anesthetic requirements without a clear increase in common adverse events. However, the average early pain reduction was below a commonly used 1-point minimal clinically important difference, and substantial heterogeneity and imprecision limit confidence in the clinical importance and generalizability of these findings (PROSPERO: CRD420251251995).
Keywords: Esketamine, laparoscopic cholecystectomy, postoperative pain, opioid sparing, meta-analysis.
Pubmed Style
Lama Alzimami, Mohammed AlAdhab, Muath Almuhanna, Rawan Alkhammas, Afnan K. Alturki, Khadijah I. Basheikh, Yousef Abdullatif Aljohar, Norah Almulhim, Wedad Almutairi, Raha Alotaibi, Aishah Alhadi, Amal Alzahrani, Abdulaziz Alabdulaali. Safety and efficacy of perioperative lowdose esketamine for pain management in laparoscopic cholecystectomy: a systematic review and meta-analysis of randomized controlled trials. AMEM. 2026; 01 (October 2026): 577-589. doi:10.24911/amem.15-3107
Publication History
Received: August 16, 2026
Revised: August 31, 2026
Accepted: September 06, 2026
Published: October 01, 2026
Authors
Lama Alzimami
College of Medicine, King Faisal University, Al-Ahsa, Saudi Arabia.
Mohammed AlAdhab
College of Medicine, King Faisal University, Al-Ahsa, Saudi Arabia.
Muath Almuhanna
College of Medicine, King Faisal University, Al-Ahsa, Saudi Arabia.
Rawan Alkhammas
College of Medicine, King Faisal University, Al-Ahsa, Saudi Arabia.
Afnan K. Alturki
College of Medicine, King Faisal University, Al-Ahsa, Saudi Arabia.
Khadijah I. Basheikh
College of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
Yousef Abdullatif Aljohar
College of Medicine, King Faisal University, Al-Ahsa, Saudi Arabia.
Norah Almulhim
College of Medicine, King Faisal University, Al-Ahsa, Saudi Arabia.
Wedad Almutairi
College of Medicine, Taif University, Taif, Saudi Arabia.
Raha Alotaibi
College of Medicine, King Faisal University, Al-Ahsa, Saudi Arabia.
Aishah Alhadi
College of Medicine, University of Jeddah, Jeddah, Saudi Arabia.
Amal Alzahrani
College of Medicine, University of Jeddah, Jeddah, Saudi Arabia.
Abdulaziz Alabdulaali
Department of Anesthesia, Northern Area Armed Forces Hospital, King Khalid Military City, Hafar Al-Batin, Saudi Arabia.